Last reviewed · How we verify
NCT03472989
Plantar Fasciopathy and the Effectiveness of Radial Extracorporeal Shockwave Therapy, Physical Training or Usual Care
NA trial testing Radial extracorporeal shock wave in Plantar Fascitis in 200 participants. Completed in 22 February 2023.
7 September 2022
Quick facts
| Lead sponsor | Oslo University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 21 March 2018 |
| Primary completion | 7 September 2022 |
| Estimated completion | 22 February 2023 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Radial extracorporeal shock wave
- Sham-radial extracorporeal shock wave
- Standardized high-load exercise program
- Usual care
Conditions studied
- Plantar Fascitis — all drugs for Plantar Fascitis →
Sponsor
Oslo University Hospital
Who can join
Adults 18 to 70, any sex, with Plantar Fascitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate whether radial extracorporeal shockwave therapy (rESWT), sham- rESWT or standardised exercise program is more effective on change in heel pain than usual care in the treatment of plantar fasciopathy. The null hypothesis is: There is no difference between rESWT, sham- rESWT or standardised exercise program on change in heel pain (primary outcome) and functioning (secondary outcomes) compared to usual care in the treatment of plantar fasciopathy at 6 months follow-up (and secondary outcomes at the 12 months follow-up). Alternative hypothesis is: H1: There is a difference between rESWT and usual care on change in heel pain (and secondary outcomes) at the 6 months follow-up (and secondary outcomes at the 12 months follow-up). H2: There is a difference between sham-rESWT and usual care on change in heel pain (and secondary outcomes ) at 6 months follow-up (and secondary outcomes at the 12 months follow-up). H3: There is a difference between standardized exercise program and usual care on change in heel pain (and secondary outcomes) at 6 months follow- up (and secondary outcomes at the 12 months follow-up).
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
The effectiveness of radial extracorporeal shock wave therapy (rESWT), sham-rESWT, standardised exercise programme or usual care for patients with plantar fasciopathy: study protocol for a double-blind, randomised, sham-controlled trial.
Heide M, Mørk M, Røe C, Brox JI, et al · · 2020 · cited 12× · PMID 32600386 · DOI 10.1186/s13063-020-04510-z -
Is radial extracorporeal shock wave therapy (rESWT), sham-rESWT or a standardised exercise programme in combination with advice plus customised foot orthoses more effective than advice plus customised foot orthoses alone in the treatment of plantar fasciopathy? A double-blind, ra
Heide M, Røe C, Mørk M, Myhre K, et al · · 2024 · cited 7× · PMID 38904119 · DOI 10.1136/bjsports-2024-108139 -
The struggle to stay physically active-A qualitative study exploring experiences of individuals with persistent plantar fasciopathy.
Mørk M, Soberg HL, Hoksrud AF, Heide M, et al · · 2023 · cited 7× · PMID 37061709 · DOI 10.1186/s13047-023-00620-4 -
Predictors for pain and functioning in patients with plantar fasciopathy one year after inclusion in a treatment trial in specialist care.
Mørk M, Soberg HL, Heide M, Hoksrud AF, et al · · 2024 · cited 2× · PMID 39702178 · DOI 10.1186/s12891-024-08187-2 -
One-Year Trajectory of Pain, Function, and Health-Related Quality of Life in Patients With Plantar Fasciopathy.
Røe C, Heide M, Søberg HL, Brunborg C, et al · · 2025 · cited 1× · PMID 40671207 · DOI 10.1002/jfa2.70067
Verify or expand the search:
- PubMed search for NCT03472989
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Plantar Fascitis
Currently open trials in the same condition.
- NCT07055698 — Responsiveness And Minimal Clinically Important Difference Of Navicular Height Drop Test With Plantar Fasciitis · active not recruiting
- NCT07037290 — Ankle Proprioceptive Neuromuscular Facilitation Technique Versus Foot Core Exercise in Patients With Plantar Fascitis · NA · active not recruiting
- NCT06536803 — Effects of High Load Strength Training With and Without Tissue Specific Planter Facia Stretching With Planter Fasciitis · NA · recruiting
- NCT06706531 — Additional Effects of Dry Needling With Conventional Physical Therapy Versus Conventional Physical Therapy in Plantar Fa · NA · recruiting
- NCT06466616 — Shock Waves Therapy Combined With Leg Stretching in Patients With Plantar Fasciitis · NA · active not recruiting
Other Oslo University Hospital trials
Trials by the same sponsor.
- NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
- NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
- NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
- NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
- NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03472989 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
- Last refreshed: 17 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03472989.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing